Create an account
Oseltamivir; Zanamivir - MOA
- neuraminidase inhibitors selective for Influenza A and B
- neuraminidase cleaves a sialic acid residue which is essential for release of the virus from infected cells and subequent spread to other cells; thereby INHIBITING THE RELEASE OF THE VIRUS FROM INFECTED CELLS
Oseltamivir - pharmacokinetics; unique usage
- given orally
- activated in the gut and liver
- excreted by the kidney
- Tx for birdflu
- some strains of influenza A (esp. H1N1) are resistant to oseltamavir
Zanamivir - pharmacokinetics
- given intranasally or by oral inhaler (not orally absorbed)
- Tx initiated 36-48 hrs after symptom onset, and lasts for 5 days
Oseltamivir, Zanamivir - side effects
- Zanamivir may WORSEN RESPIRATORY FUNCTION in pts. with chronic obstructive pulmonary disease or cause BRONCHOSPASMS in asthmatics; also causes throat discomfort
- Oseltamivir may cause NAUSEA and VOMITING which is reduced if taken with food
Amantadine, Rimantadine - MOA
- block uncoating of virus; inhibit release of viral nucleic acids into the cell cytoplasm
Amantadine, Rimantadine - pharmacokinetics
- well absorbed orally
- plasma t1/2 about 20 hrs
90% excreted unchanged by the kidney; 10% is metabolized
Amantadine, Rimantadine - uses
- prevention and Tx of INFLUENZA TYPE A2 (ASIAN FLU) in HIGH RISK PTS.
- PROPHYLACTIC use reduces incidence and severity of symptoms
- treatment may decrease duration of symptoms by 1-2 days
Amantadine, Rimantadine - Side Effects
- NAUSEA, dizziness, occasional vomiting are common
- amantadine is amild dopamine agonist and may cause CNS effects: HALLUCINATIONS, confusion, anxiety, irritability, anorexia
- rimantadine does not cross the BBB and doesn't have CNS effects
- teratogenic in animals
- rarely used since the introduction of oseltamavir
Ribavirin - MOA
- phosphorylated by cellular enzymes to ribavirin-5'-triphosphate
- INHIBITS VIRAL mRNA SYNTHESIS, protein synthesis and viral replication
- may have a greater affinity for inhibition of viral RNA synthesis than host RNA synthesis
Ribavirin - uses
- inhibitory against RSV, herpes simplex and influenza
- combined with interferon for treatment of Hepatitis C
- hospitalized infants and young children wiht severe lower respiratory tract infection caused by RSV
Ribavirin - pharmacokinetics
- AEROSOL ADMINISTRATION 12-20 HRS PER DAY FOR 3-7 DAYS; respiratory tract concentration 100% higher than plasma
- high dose IV therapy may be life saving in LASSA FEVER
- used orally with INTERFERON-ALFA 2b or 2a for treatment of HEPATITIS C, where it improves the liklihood of response to interferon considerably
Ribavirin - toxicity
- PREGNANCY CATEGORY X - teratogenic: both patient and partner must avoid pregnancy
- DYSPNEA, CHEST SORENESS, CARDIAC ARREST, HYPOTENSION
- pulmonary function may decline in pts. with pre-existing pulmonary disease
- HEADACHE, GI problems, insomnia, lethargy, DYSPNEA may occur with oral use
- dose-dependent ANEMIA, DEPRESSION and suicide may occur with oral use
- MAY BE ABSORBED PASSIVELY BY STAFF WORKING WIHT PATIENTS DURING AEROSOL TREATMENT...SHOULD NOT BE ADMINISTERED BY PREGNANT WOMEN!!!
Please allow access to your computer’s microphone to use Voice Recording.
Having trouble? Click here for help.
We can’t access your microphone!
Click the icon above to update your browser permissions and try again
Reload the page to try again!Reload
Press Cmd-0 to reset your zoom
Press Ctrl-0 to reset your zoom
It looks like your browser might be zoomed in or out. Your browser needs to be zoomed to a normal size to record audio.
Please upgrade Flash or install Chrome
to use Voice Recording.
For more help, see our troubleshooting page.
Your microphone is muted
For help fixing this issue, see this FAQ.
Star this term
You can study starred terms together